Abstract
Bioceramics have frequent use in functional restoration of hard tissues to improve human well-being. Additive manufacturing (AM) also known as 3D printing is an innovative material processing technique extensively applied to produce bioceramic parts or scaffolds in a layered perspicacious manner. Moreover, the applications of additive manufacturing in bioceramics have the capability to reliably fabricate the commercialized scaffolds tailored for practical clinical applications, and the potential to survive in the new era of effective hard tissue fabrication. The similarity of the materials with human bone histomorphometry makes them conducive to use in hard tissue engineering scheme. The key objective of this manuscript is to explore the applications of bioceramics-based AM in bone tissue engineering. Furthermore, the article comprehensively and categorically summarizes some novel bioceramics based AM techniques for the restoration of bones. At prior stages of this article, different ceramics processing AM techniques have been categorized, subsequently, processing of frequently used materials for bone implants and complexities associated with these materials have been elaborated. At the end, some novel applications of bioceramics in orthopedic implants and some future directions are also highlighted to explore it further. This review article will help the new researchers to understand the basic mechanism and current challenges in neophyte techniques and the applications of bioceramics in the orthopedic prosthesis.
Keywords: bioceramics, additive manufacturing, scaffolds, bone tissue engineering
1. Introduction
Additive manufacturing or 3D printing has got attention in scaffold design and manufacturing for tissue engineering applications. Initially, this technique was developed by Sachs et al., to create the ink-jet freestyle printing towards the latter part of the 20th century [1]. Later on, it was extended in tailoring the perfect scaffolds on its user-friendly capabilities, which considered the transformation of computer aided design (CAD) information to a rapid and reliable production line of constructs with the coveted material, porosity, and measurements [2,3]. Moreover, it showed a time and cost-efficient potential coupled with interconnected structures, specifically hard tissue deformity regeneration.
Recently, clinical preliminaries and contextual analyses revealed its resounding accomplishments in the field of orthopedic bioengineering. While this procedure has shown significant potential, specific difficulties tend to enhance patient-particular scaffolds for standard acknowledgment in regenerative medicine [4,5,6].
During the past few decades, many advanced biomaterials were introduced in the biomedical field including different ceramic materials for the skeletal repair and reconstruction. These materials in the field of medical implants are often referred to as “bioceramics” [7]. Bioceramics are peculiar in nature due to their exceptional biological and osteoinduction properties. These materials are specific for scaffolds due to capability to create propagation, self-adhesion, distinction and bone tissues regeneration [8]. Furthermore, excellent chemical and mechanical properties such as better osteoconductivity, superior wear resistant and biocompatibility enabled them as a substitute for bone restoration, [9,10]. It can anticipate that bioceramics have a future due to increasing bone replacement operation per year due to increasing aging population [11].
The clinical importance of AM ceramic scaffold design and implantation envelops an invaluable method for quick and reliable production of hard tissue substitution replica of the biological context of natural bone [12]. In view of the way that customized scaffold can be prepared that suits an individual patient’s skeletal imperfection, layer-by-layer sintering is regarded as a lucrative discipline for the utilization of ceramic-based bone substitutes in regenerative medicine [13]. Besides, utilizing AM ceramic scaffolds as medication conveyance systems, it is becoming more attractive and relevant to the bioengineering environment [14,15,16].
This article is divided into six sections; Section 1 details the bioceramics potential, Section 2 offers an overview of the AM techniques used to fabricate ceramic parts. Section 3 presents achievements in the production of hydroxyapatite (HA); Section 4 depicts about tricalcium phosphate (TCP) and Section 5 describes about bioactive glass (BG) using different AM techniques. Section 6 concludes some important findings with some current challenges and future opportunities in this field.
2. Additive Manufacturing Technologies to Produce Ceramic Parts
Additive manufacturing has been classified into two major classes such as acellular and cellular techniques for biomaterials. The cellular category includes the printing of live cells, while the acellular category does not consider any type of live cells in printing. Figure 1 shows different acellular AM techniques for biomaterials that have been classified as per recommendations of American Society for Testing of Materials (ASTM) [17]. The major AM techniques employed in the processing of bioceramics have been discussed in the following section.
2.1. Binder Jetting
Binder jetting technique was developed in the early 1990s at Massachusetts Institute of Technology (MIT) [18]. Figure 2 depicts the schematic of binder jetting. In this technique, the binder is selectively used from powder bed to create 3D objects. Binder jetting is a valuable technique for printing powder materials [19,20]. The particle size of the powder has a key influence on powder flowability in binder jetting.
For dry binder jetting, large size particles are preferred due to its outstanding flowability and less surface area. The powder size not only affects the flowability but also significantly affects the quality of the final product. Numerous researchers have reported less surface roughness using fine powder in the binder jetting. The effect of the powder shape is less, as compared to the powder size. However, spherical shape powders have better flowability and lesser friction compared to faceted powders [21,22,23].
2.2. Direct Energy Deposition (DED)
Direct energy deposition-based AM techniques uses energy into a small region to simultaneously deposit, melt and solidify the material such as wire or powder [24]. The direct energy source can be electrical, or laser beam can be used to melt the metal, ceramics or composite materials. Laser assisted Direct Deposition techniques such as laser cladding, laser engineered net shaping (LENS™), and laser melt injection are common examples of this technique.
In ceramic Direct Energy Deposition (DED), the printing head of the apparatus contains a nozzle that feeds ceramic powder particles to the focal point of the laser beam. The ceramic powder melts and solidifies in layer-wise fashion on a substrate [25]. Figure 3 is the schematic illustration of LENS [26].
The major advantages of DED are better compatibility with a wide range of biomaterial viscosities, higher resolution and greater cell density that provide higher control of cell-to-cell adhesions [27]. Besides these advantages, DED has many challenges such as, low speed, cost, high complexity and limited capability to manufacture heterogeneous tissue parts [28]. Due to these challenges, the usage of DED is very limited as compared to other AM techniques particularly in bone tissue engineering. The DED technology needs more research to enhance its productivity.
2.3. Material Extrusion and Jetting
Extrusion assisted additive manufacturing deposits a continuous layer by layer deposition of ceramic loaded paste to create 3D objects. Various terms are used to refer to this technology for instance, Fused Deposition of Ceramics (FDC), Robocasting, Extrusion Freeform Fabrication (EFF), Direct Ink Writing (DIW), Slurry Deposition, and Dispense Plotting [29].
In Fused Deposition, dense ceramic particles (up to 60 vol%) are spread into a wax or thermoplastic filament after which the flexible filament is partly melted and extruded from a moving deposition head onto a fixed worktable layer-by-layer. However, in robocasting, ceramic slurry is ejected from a precise nozzle to form a filament that is directly deposited in a designed pattern to create complex 3D objects in a layer-by-layer fashion [30].
In another research work, an indirect Fused Deposition Modeling (FDM) method was applied to prepare ceramic parts. At the preliminary stage, FDM was used to prepare a honeycomb shaped polymer structural mold. Secondly, the ceramic slurry was permeated into the polymer mold-sintering to remove the mold. The porous ceramics made a correct pore size and porosity through this technique [31].
Another technique named Extrusion-based bioprinting has also a greater potential in perspective of deposition and printing speed compared to other AM techniques. This technique is also beneficial to achieve better scalability in a shorter time [32], wide range flexibility of bioinks selection [33]. This is because developing new bioinks is a critical procedure for quick, sustainable and safe delivery of cells in a biomimetic microenvironment [32]. Besides many advantages, some complexities are also associated with this technology such as low resolution and shear stress effect on cells. The schematic of the process with part microstructure was shown in Figure 4.
The material jetting techniques are the “AM processes in which droplets of build material are selectively deposited” [17], that can be used to manufacture different kinds of ceramic parts. Inkjet 3D printing technology was among the first material jetting AM techniques that were employed for additive manufacturing of ceramic parts. It was developed by Sachs et al. in 1992 at MIT and defined as a process for the manufacturing of ceramic casting cores and shells using inkjet 3D printing [1]. Figure 5 shows the Schematic of ink-jet 3D printing [34].
2.4. Powder Bed Fusion
Powder bed fusion (PBF) technologies are among pioneer commercially used AM techniques created by the University of Texas USA. Selective laser sintering (SLS) based PBF technique [18], which melts the ceramic powder by laser energy source. The laser sintered the powder nearly to the melting point of the material to make each layer according to the given 3D design. The laser beam scans each new single layer of free-packed powder particles and consolidates them by sintering this process and proceeds in a layer-wise fashion to complete the final 3D object [35,36,37]. SLS is a powder bed fusion process have numerous applications in the bioengineering field such as to prepare customized products, biomedical implants as well as orthopedic implants [38]. The major disadvantage of SLS is the usage of higher temperatures that limits the insertion of biomaterial and cells into SLS scaffolds during the manufacturing process [39]. A schematic diagram illustrates the underlying operating system [40] of the powder bed fusion provided in Figure 6. While SLS technology is amended, the PBF method to increase machine efficiency.
2.5. Vat Polymerization (SLA)
Vat Polymerization also known as stereolithography (SLA) is a promising AM technique to fabricate tissue scaffolds in the field of regenerative medicine. The SLA technique has exceptional control over porosity of scaffolds, pore sizes, design flexibility, and interconnectivity [41]. Despite excellent advantages, numerous researchers have highlighted several challenges in scaffold manufacturing such as, difficult in creating micron-sized scaffold due to over curing and layer thickness. In addition, some of the frequently used biomaterials in bone tissue engineering have shown compatibility with SLA due to limitations in viscosity, refractive index and stability [42].
Some other problems such as some SLA processes light pixels restrict in-plane microstructure construction. Although indirect SLA have overcome this problem, it is a costly, time and material consuming process [43]. Li et al. have used indirect stereolithography to manufacture microporous β-TCP. The resin molds were prepared through this technique and filled with filled with aqueous thermosetting ceramic suspension for ceramic gel casting. The heat treatment process was used to remove the molds. Results have concluded that TCP scaffolds after sintering have shown desired porosity, shape and higher strength were obtained [44].
Some other researchers have mentioned preparation of 3D objects by photo-curing a liquid resin through ultraviolet (UV) laser in a layerwise fashion [45,46]. The major advantage of this process includes better surface finish and accuracy [47]. A schematic of three different light sources used in stereolithography provided in Figure 7 [18]. Table 1 summarizing some basic bioprinting techniques for bone tissue engineering.
Table 1.
Technique | Principle | Advantages | Drawbacks |
---|---|---|---|
Inkjet | A liquid binding material is selectively deposited in layer-wise fashion into the powder bed to create three dimensional objects. | Ability to print biomaterials with low viscosity, high resolution, fast manufacturing speed, low cast | Intrinsic inability to deliver a continuous flow, low cell densities, lack of functionality for vertical objects |
Extrusion | This process involves extruding the material in viscous form to create 3D objects | Capability to print variety of biomaterials, Capable of printing high cell densities | Applicable to viscous liquids only |
Laser-assisted | In this technique, a laser beam stimulates a specified area of target to fabricate 3D objects | High resolution, capable of printing both solid and liquid phase biomaterials | High cost, low speed, high complexity, thermal damage due laser irritation |
Stereolithography (SLA) | In this method an ultraviolet (UV) laser beam selectively hardens the photo-polymer resin to construct 3D models in layer-wise fashion | Nozzle free method, high cell viability, high accuracy, Printing time independent of complexity, high cell viability, high accuracy | UV light can cause toxicity to cells, during photo curing damage to cells, Applicable to photopolymers only |
3. Additive Manufacturing of Bioceramics
In the last few decades, bioceramics have frequently been used in the restoration and replacements of injured tissues due to numerous advantages such as precise chemical composition, which has a vital role in the integration of hard and soft tissues [48,49]. Hydroxyapatite (HA) () is one bioceramic to have frequently been employed as a scaffold material for bone tissue engineering owing to its exceptional biocompatibility and resemblance to natural bone material [50,51,52]. It is often combined with a biopolymer or bioceramics to enhance binding interaction and mechanical properties of the material during the AM process [53,54].
Beta tri-calcium phosphate (-TCP) is a suitable material for craniofacial defects owing to its excellent biodegradability, wear resistance and chemical bonding with the bone tissues under all load bearing conditions [55,56]. The critical challenge for -TCP is to maintain the sintering temperature of 1100 °C. Above this temperature, beta tri-calcium phosphate -TCP) transforms to alpha tri-calcium phosphate -TCP) that is soluble and chemically unstable, as compared to -TCP [57,58].
In addition, bioglasses are also extensively used in hard tissue implants due to their excellent bonding capability with hard and soft both tissues. Bioglasess are also extremely helpful in upregulating the osteogenesis, however, their application in load bearing bone defects are very limited due to their high brittleness, low fracture toughness and mechanical strength [59,60,61]. Properties of some frequently used ceramic material for bone tissue engineering illustrated in Table 2.
Table 2.
Materials | Precursors | Properties |
---|---|---|
Hydroxyapatite (HA) | Poly (acrylic acid), photo-curable resin, polycaprolactone, poly (lactic acid) etc. | Higher biocompatibility, differentiation and proliferation, better cell adhesion |
Tricalcium Phosphate (TCP) | Hydroxypropyl methylcellulose, polyethylenimine, polymethacrylate, etc. | In physiological environment better biocompatibility and degradation, lower compressive strength |
Bioactive glasses alkali-free bioactive glass, 45S5 BG,13-93 bioactive glass, 6P53B glass | Polycaprolactone, methylcellulose, poly (lactic acid) | Improved bioactivity in vitro and in vivo for the bone tissue growth |
The key factor affecting the performance of bioceramics is Ca to P ratio that affects the dissolution property. Calcium phosphates with lower Ca to P ratio (-TCP) have higher solubility and acidic nature as compared to calcium-phosphate having high Ca to P ratio (HA) [62]. Table 3 shows that lower the Ca/P ratio higher the CaP dissolution [63]. Different bioceramics have been discussed in the following section such as hydroxyapatite, beta tri-calcium phosphate (-TCP) and bioactive glass (BG) using different AM techniques. Figure 8 [64] shows complete process of bone tissue engineering.
Table 3.
Name | Formula | Ca/P Ratio | Water Solubility at 25 °C, g/L |
---|---|---|---|
Monocalcium Phosphate | |||
Monohydrate (MCPM) | Ca(H2PO4)2, H2O | 0.50 | 18 |
Anhydrous (MCPA) | Ca(H2PO4)2 | 17 | |
Dicalcium phosphate | |||
Dihydrate (DCPD) | CaHPO4, H2O | 1.00 | 0.088 |
Anhydrous (DCPA) | CaHP4 | 0.048 | |
Tricalcium Phosphate | |||
Alpha -TCP | (PO4)2 | 1.50 | 0.0025 |
Beta -TCP | ) (PO4)2 | 0.0005 | |
Hydroxyapatite (HA) | Ca5(PO4)3OH | 1.67 | 0.0003 |
3.1. Hydroxyapatite (HA)
Hydroxyapatite (HA) portrayed as (), encompasses almost 65% of the entire bone mass. It is less toxic and more stable, as compared to other calcium-phosphate due to their desirable Ca to P ratio of 1.67. The hydroxyapatite has major inorganic part of human bone and teeth to develop the properties and novel applications of bioceramics for hard tissue replacements [65,66,67,68]. Numerous researchers have reported HA scaffolds in the bone and teeth transplants [69,70,71,72,73,74,75,76,77].
Laser Stereolithography has been identified as one of the most effective and frequently used AM techniques to produce complex HA parts. Barry et al. have prepared HA-based oligocarbonate dimethacrylate (OCM-2) composite scaffolds using helium-cadmium (HeCd) based laser technology. The outcomes referred the laser-based HA scaffolds provided fortified cell attachment inside the scaffold. Through laser machining, toxic leftovers were removed effectively through supercritical carbon dioxide (scCO2) to make scaffolds biocompatible. The HA based composite materials treated by scCO2 showed better attachment of cells in both vivo and vitro studies [78]. In a very recent study, a bio-ink was prepared for 3D printing by dispersing two different types of hydroxyapatites, nano hydroxyapatite (nHA) and deproteinized bovine bone (DBB) into collagen. Thereby, a porous structure was created by 3D printing. The chemical and physical properties of the materials, including biocompatibility and effect on the osteogenic differentiation of the human bone marrow-derived mesenchyme stem cells (hBMSCs) were investigated. Both nHA/CoL and DBB/CoL Bio-inks were used to print biomimic 3D scaffolds effectively. The outcomes from this study showed that the two types of hydroxyapatite composites which help hBMSCs proliferation and differentiation proved to be a promising candidate for a 3D scaffold bio-ink [79].
Woeszn et al. fabricated microporous HA scaffolds having a pore size of 450 µm through stereolithography coupled with ceramic gelcating. A photosensitive liquid resin filled with water based thermosetting slurry was used in the mold. The mold resin and sintering were burnt to achieve the desired features. The final Scaffolds were seeded on MC3T3-E1 cells for 14 days under deep penetration of cells to achieve outstanding osteogenesis as shown in Figure 9 [80].
The AM based extrusion process is also very common to manufacture HA scaffolds. The robocasting based extrusion process contains ceramic ink in the form of water-based viscous slurry deposited on a robotic nozzle in layer-wise fashion based on computer-aided design. The process contains high loading of HA particles to minimize the cracks and distortion during sintering. Saiz et al. have fabricated HA scaffolds with controlled pore sizes through robocasting extrusion to find the optimum sintering temperature. The hydroxyapatite slurry was prepared by mixing 40–50 vol.% of HA powder in distilled water, 1.5 wt% of Darvan C dispersant, (7 mg/mL of solution) hydroxypropyl methylcellulose, an adequate amoqunt of polyethyleneimine (PEI) and at the end or to balance the pH level of the slurry. Results concluded that porous HA scaffolds manufactured with robocasting showed the sintering temperature should remain between 1100 °C1200 °C and no phase change was observed for firing 1300 °C for 3 h. The characteristics of printed scaffolds through this technique have been presented in Figure 10 [81].
Keriquel et al. have successfully printed the nano-HA scaffold in the mouse calvaria defect model in vivo using laser-assisted additive manufacturing. The printed cells showed the existence of vivacious blood vessels after bone defect treatment. The outcomes of this study demonstrated that laser-assisted bioprinting have perfectly treated bone defects. Through literature numerous authors have mentioned potential of this technology could offer new perspectives to additive manufacturing for the practical applications of bone tissue engineering [82].
3.2. Tricalcium Phosphate (TCP)
Since the last two decades, beta tri-calcium phosphate (-TCP) ceramic-based scaffolds have clinically accepted the bone graft replacement materials in several orthopedic and dental applications [83,84,85,86,87,88,89]. The TCP contains and phases and Ca to P ratio is about 1.5. Cao et al. manufactured sphingosine 1-phosphate (S1P) coated -TCP scaffold. Immunoregulation capability was tested on macrophages and rat bone marrow stromal cells of the coated scaffold was used to test osteogenic capability. The scaffold exhibit improved osteogenesis, better cell compatibility and also helpful to regulate the immune response as compared to traditionally manufactured scaffold. Figure 11 is the representation of 3D printed scaffold and its cell viability [90].
Bian et al. introduced a novel stereolithographic method to produce osteochondral beta-tricalcium phosphate/collagen scaffold. This bio-inspired scaffold manufactured by a combination of ceramic stereolithography (CSL) and gel casting using (-TCP) and type-I collagen. Histological examination was performed to investigate the morphological properties between cartilage and bone. The obtained information from this examination were used to design biomimetic biphasic scaffolds. The pores size of -TCP scaffolds varied between 700–900 µm with 50–65% porosity and compressive strength of 12 MPa. Physical locking formed by biomimetic transitional structure was used to achieve an adequate binding force among cartilage phase and a ceramic phase. The results concluded that CSL performed well in comparison with traditional techniques to get an ideal scaffold for bone tissue engineering applications [91].
In a recent study, Bose et al. have investigated the effect of and dopants on the bio-mechanical properties of 3D printed -TCP scaffold in a rat distal-femur for the period of 4, 8 and 12 weeks. The scaffold was fabricated by binder jetting technique using synthesized -TCP powder. The outcomes from this analysis demonstrated that the addition of to TCP scaffold speed up the early stage bone restoration boosting type I collagen production. doped TCP scaffold showed neovascularization after 12 weeks as shown in Figure 12. The finding from this study proved that ceramic powder-based scaffolds with improved chemistry has a promising future in bone defect restoration [92]. Tarafder et al. manufactured -TCP scaffolds with 27%, 35% and 41% designed macroporosity with pore sizes of 500 µm, 75 µm and 1000 µm, respectively by 3D printing method. After that the scaffolds were sintered at the temperature of 1150 °C to 1200 °C in conventional and microwave furnaces to achieve mechanical strength. Microwave sintering heated scaffolds showed higher mechanical strength, as compared to conventional sintering.
The pore size was examined by Human osteoblast cells. This study showed that a decline in pore size from 1000 to 750 and 500 µm has increased the cell density. Histomorphology tests in femoral defects of Sprague-Dawley rats revealed that the existence of both micro and macro pores accelerated the new bone construction. It was concluded that additive manufactured TCP scaffolds have outstanding potential in hard tissue engineering applications [93].
3.3. Bioactive Glass (BG)
Bioactive glasses (BG) are the type of bioceramics that exist in both nonporous and solid forms. The bio glass contains silicon dioxide, sodium oxide, calcium oxide and phosphorous. Different types of bioglass have been created by varying the vol.% of these components [94]. Silicate part plays have an essential role in the biocompatibility of bioactive glasses. The bio glass with 45–52 vol.% silicate has ideal bone-graft bonding [95]. The 45S5-bioglass is a well-known commercially available extensively used in bone replacement [96]. However, bioglasses have also some limitations due to poor mechanical properties and brittleness that makes them unsuitable for load-bearing applications, internally brittle and deficient mechanical strength. However, several researchers have reported different additives, such as metal, polymer and ceramic to enhance the mechanical properties [97,98,99,100,101].
Recently, Nommeots-Nomn et al. robocasted bioglass scaffolds with a 150 µm interconnected pore size (41–43% porosity) and measured compressive strengths were 32–48 MPa. The network connectivity (NC) of these scaffolds is like the 45S5 bioglass. In this process, ICIE16 and PSrBG compositions were used comprising < 50 mol% Si to maintain the amorphous structure and to achieve the required NC closer to 45S5 bioglass. The manufactured scaffolds were compared with 13–93 vol.% composition bioglass. The comparison highlighted that 3D porous scaffolds have similar NC values with 45S5 bioglass using two low silica contents. In addition, Pluronic F-127 binder could be accepted as a universal binder for bioactive glasses regardless of their composition and reactivity. Results also showed that ICIE16 and PSrBG based scaffolds are highly reactive and significantly enhanced the bone regeneration speed [102].
Padilla et al. used calcined bioglass suspension to fabricate porous scaffolds through integrating the stereolithography and gel-casting method. A polymeric negative mold was used via stereolithography to cast bioglass suspension with Darvan-811 (sodium polyacrylate) as a dispersant. The slurry containing 50 vol% was heated at 1100 °C for 55 s and later it was polymerized. The negative mold was removed by heat treatment. The scaffolds containing interconnected 3D channels of 400–470 µm length and 1.4 µm of pore diameter. The results illustrated that the entire interconnected porous scaffold was created by this method [103].
Westhauser et al. inspected the osteo-inductive properties of different polymer coated 3D-45S5 bioglass scaffolds. These scaffolds are seeded with human mesenchymal stem cells (hMSC) implanted into immunodeficient mice. The gelatin, cross-linked gelatin, and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) type coatings were used. histomorphometry and micro-computed topography analysis were performed to evaluate the new formation after eight weeks of implantation. Although, every bioglass scaffolds showed noticeable bone regeneration. However, gelatin-coated bioglass scaffolds showed highest cell formation in comparison with other coated-bioglasses, as shown in Figure 13 [104]. Some latest researches on 3D printing of bioceramics have been compiled in Table 4.
Table 4.
Material | Process | In Vivo/In Vitro Model | Key Findings | Ref. |
---|---|---|---|---|
HA + liquid sodium polyacrylate + photopolymer | A ball crusher was used to milled all the materials for 12 h to make a slurry with solid content of 10~60 wt%. The ceramic scaffold was fabricated by using digital light processing (DLP) technique | Mouse osteoblast precursor cells (MC3T3.E1) were cultured in the condition of -MEM (10% fetal bovine serum 4% penicillin-streptomycin) | 3D printed scaffold showed better biocompatibility, adhesion, differentiation and also able to promote osteoblast proliferation | [105] |
Biphasic calcium phosphate (HA/-TCP = 60:40) + HMPC+ polyethylenimine + Zr | Extruded at pressure of 600 kPa with printing speed of 100 mm/min. Constructs were sintered at 1100 °C | Investigated on osteoblast like sarcoma cells for cytotoxicity and for differentiation potential of the scaffolds hMSCs cells were used | Better mechanical properties of scaffolds at 10% (w/w) of Zr was observed with improved BMP-2 expression. | [106] |
TCP/polycaprolactone | -TCP powder with 550 nm particle size were used to fabricate 350 µm pore size cylindrical scaffolds. | Composite scaffolds were tested using human fetal osteoblast cells (hFOB) for 3, 7 and 11 days of incubation period | Enhanced early bone formation and effective for controlled alendronate release | [107] |
TCP/sphingosine 1-phosphate (SIP) | The scaffolds were printed in four layers and in different sizes to fit in 6-well and 12-well plates. Printed scaffolds were sintered at 1100 °C for 3 h. | Immunoregulation capability was investigated on macrophages and the osteogenic capability was tested on rat bone marrow stromal cells of the coated scaffolds. | Good biocompatibility, improved bone regeneration process | [90] |
Bioactive glass/alginate | Composite scaffolds of type 13-93 bioactive glass (13-93 BG) and sodium alginate (SA) were prepared with mass ratio of 0:4, 1:4, 2:4 and 4:4 under mild conditions for bone regeneration. | The apatite mineralization abilities of the 13-93 BG/SA scaffolds were tested by soaking scaffolds in simulated body fluid (SBF), using 200 mL of scaffold mass, at 37 °C for 0 and 10 days. | Improved porosity and reduced shrinkage ratios | [108] |
Bioglass (BG)/gelatin/cross linked-gelatin/ploy (3-hydroxybutyrate-co-3-hydroxyvalerate) | Three different types of 3D-polymer coated BG (45S5-type) scaffolds were fabricated by the well-established foam replica method and coated with the biopolymers. | Osteo-inductive properties of 3D-45S5 bioglass scaffolds were investigated by seeding human mesenchymal stem cells (hMSC) implanted into immunodeficient mice for the period of 8 weeks. | Under standard conditions biopolymer coated 3D 45S5 BG scaffolds have ability to induce bone formation. Gelation coated scaffolds showed the best results. | [104] |
4. Application of Bioceramics in Orthopedic Implants
Natural bone has self-repair capability after the damage. The smaller fractures heal itself correctly, however segmental bone defects (SBDs) lead to permanent paralysis [109,110]. SBDs fractures treated with autologous bone graft technique requires harvesting of non-vital bone, such as, the iliac crest.
However, some complexities are also associated with bone grafting such as bone availability, the mismatch between harvested bone and affected site, morbidity of donor site results in poor integration [111]. Over the past three decades, a variety of synthetic materials have been introduced to overcome the complexities such as calcium phosphates (bioactive glasses) and hybrid bioceramics-polymer materials [112,113,114,115]. Table 5 showing different materials for bone tissue engineering.
Table 5.
Material | Binder | Layer Thickness | References |
---|---|---|---|
TCP | Aqueous based | 20 µm | [93] |
HA | - | 100 µm | [116] |
-TCP modified with 5 wt% hydroxypropymethylcellulose | Water | 100 µm | [117] |
-TCP, Si-ZnO-dope -TCP |
Water based binder | 20 µm (β-TCP) 30 µm (SiO2-ZnO-doped β-TCP) |
[118] |
HA | -n-butyl cyanoacrylate (NBCA) | - | [119] |
TCP | 20% (v/v) phosphoric acid |
125 µm | [120] |
TTCP/-TCP | 25% citric acid | 100 µm | [121] |
-TCP | 10 wt.% phosphoric acid | 50 µm | [122] |
HA/Maltrodextrin | Water based | 175 µm | [123] |
HA & Maltrodextrin/apatite-wollastonite glass | Water based | 100 µm | [124] |
Roohani-Esfahani et al. fabricated glass-ceramic scaffolds with hexagonal pore structure via extrusion-based AM method shown in Figure 14. The fabricated scaffolds have 150 times greater strength compared to polymeric-composite scaffolds and five times greater than ceramic-glass scaffolds having same porosity. The study has shown that these scaffolds have excellent capability to load-bearing and segmental bone defects treatment [125].
Fierz et al. prepared HA based cylindrical scaffolds ranging from nanometer to millimeter with straight channels and micro-pores through n-HA granules, ink-jet 3D printing AM technique. The structure of 3D-printed scaffolds is almost similar to human cortical and cancellous bone. The histological analysis has confirmed that osteogenic-stimulated progenitor-based 3D-printed scaffolds are suitable for clinical use [126].
In another study, a robocasting technique was utilized to transport bone morphogenic protein 2 (BMP-2). HA slurry and polymethylmethacrylate (PMMA) microspheres were mixed together to achieve controlled microporosity. Resins were eliminated by sintering the scaffolds at 1300 °C for 2 h. Thereafter, 10 µg of bone morphogenic protein 2 was added to the microporous scaffolds in goat bone for in vivo characterization for 4 and 8 weeks. Outcomes from this study showed great potential for manufacturing HA scaffolds containing interconnected porosity. Furthermore, the existence of bone morphogenic protein 2 and micro porosity upgraded scaffold osteogenesis ability as illustrated in Figure 15 [127].
Fielding et al. introduced (Si/ZnO) doped three-dimensional composite TCP scaffolds with a pore size of 300 µm using binder jetting technique. The pure and (Si/ZnO) doped 3D-printed TCP scaffolds implanted into a rat femur bone for the period of 6, 8 and 12 weeks to analyze the histomorphometry and Immunohistochemistry. Results have proved that combining Si-ZnO dopants in TCP are best alternative to achieve osteoinductive properties of calcium phosphates (CaPs) for the clinical application of bone implants as shown in Figure 16 [118].
5. Challenges and Future Perspective
Despite all the achievements made in the past in 3D printing of tissue engineering, several challenges still exist. Challenges can be divided into two major categories: (1) 3D printing of biomaterials including live cells and (2) Post-implantation integration and functionality in vivo model. One of the most common problems during manufacturing is nozzle clogging in nozzle-based 3D printing techniques. To overcome nozzle clogging, printing precursor should have proper viscosity and need to be homogenous. Another problem is that the 3D printed constructs need to be adequately stable and mechanically stiff to ensure effective prosthesis. For instance, in hard tissue transplant, the scaffolds elastic modulus should be high enough to sustain its designed porosity and structure to help natural cell growth [128].
3D printed constructs for bone tissue engineering, being eventually implanted in a body, so these constructs also need to support vascularization to deliver sufficient amount of oxygen and nutrition to the cells in vivo to enhance the growth of newly implanted bone [129]. Vascularization plays a pivotal role in a successful bone tissue implant. However, it remains a daunting challenge in bone tissue engineering, particularly, in clinical application of large bone defects. Development of vascularized and clinically applicable bone substitutes with adequate blood supply, capable of inducing angiogenesis and sustaining implant viability remains a critical challenge. Since oxygen is only accessible to those cells through diffusion that are 100–200 µm from blood vessels, bioprinted constructs thicker than 400 µm face oxygenation problem. Therefore, it is a critical task to provide ideal conditions to help vascularization in implanted bone constructs. There is a need for some extensive research to completely understand the mechanism of the biological system of bone. Thus, manufacturing a biomimetic vascularized bone that mimics the native bone can be helpful to overcome these hurdles. Due to the ability of bioprinters utilizing several print-heads loaded with different cell types, introducing vasculature was made possible to a 3D printed construct [130,131,132].
Recently, nozzle-based 3D-printers enabled the printing of endothelial cells using multiple bioinks for the development of thick vascularized [133,134]. Especially, digital light processing (DLP) based 3D bioprinting can offer extraordinary speed, scalability and resolution for printing complex 3D structures with micrometer resolution [135,136]. For instance, Zhu et al. printed well-designed vascular channels without using perfusion or sacrificial materials by utilizing a rapid microscale continuous optical bioprinter (). In this method, glycidyl methacrylate-hyaluronic acid (GM-HA) and GelMA-cell laden bioinks were used to create channels and channel adjacent regions. From the outcomes of this study, researchers were able to demonstrate the progressive formation of endothelial network and formation of the lumen-like structures in vivo/vitro model. Anastomosis between the bioprinted endothelial network and circulation was observed with functional blood vessels featuring red blood cells [137]. Moreover, hypoxia is also having an important role in vascularization and bone regeneration process. Hypoxia belongs to the family of Hypoxia-Inducible Transcription Factors (HIFs) [138]. Kuss et al. utilized short-term hypoxic conditions to endorse vascularization in a hybrid 3D printed scaffold of polycaprolactone/hydroxyapatite (PCL/HAp) and stromal vascular fraction (SVF) derived cell laden bioink [139].
Another type of challenge is regulatory hurdles, customized 3D printing technology entails series of difficulties in the regulatory approval field. Though, it is urgent for the managing authorities to establish appropriate laws and regulations to ensure sustainable progress of 3D printing technology. At present, 3D-printed scaffolds and tissues are used for evaluation and screening purposes in animal models.
6. Conclusions
In summary, this review outlined the latest researches on development of 3D printing of bioceramics for bone tissue engineering, current state of the art is also discussed. Extensive amount of research on 3D bioprinting over the past 10 years highlighted its wide range of applications and potentials in bone tissue engineering. Although, plethora of goals have been accomplished in 3D printing of bioceramics, but it is still in its emerging stage.
However, to deal with challenges such as vascularization, and printing related problems, further research on development of bioinks, integration of different 3D bioprinting technologies, improvement of the mechanical properties of existing bioceramics, development of composites with excellent biocompatibility and better understanding of bonding mechanism between bone mineral and collagen are some primary areas of concern that can help to improve the applications of 3D printing in bone tissue engineering.
Recently, a very limited number of bio-printed products have been commercially available. Due to the rapid expansion of this industry in the last few years, it is foreseeable that more bio-printed constructs will ultimately become commercially available to help wide range of patients suffering from different kind of diseases. The technical problems related to clinical requirements and materials selection are mentioned above, multidisciplinary research will be required to tackle those problems and to comprehensively understand the potential of bioprinting in bone tissue engineering.
Author Contributions
Conceptualization, Methodology, Original draft preparation and data curation; M.J.Z. and D.Z. contributed equally; formal analysis, revision and supervision done by D.Z. and Z.Z.
Funding
This work had been financially supported by the Natural Science Foundation of Hebei Province, China (E2018202200).
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Sachs E., Cima M., Williams P., Brancazio D., Cornie J. Three-Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD Model. J. Eng. Ind. 1992;114:481–488. doi: 10.1115/1.2900701. [DOI] [Google Scholar]
- 2.Malik H.H., Darwood A.R.J., Shaunak S., Kulatilake P., El-Hilly A.A., Mulki O., Baskaradas A. Three-dimensional printing in surgery: A review of current surgical applications. J. Surg. Res. 2015;199:512–522. doi: 10.1016/j.jss.2015.06.051. [DOI] [PubMed] [Google Scholar]
- 3.An J., Teoh J.E.M., Suntornnond R., Chua C.K. Design and 3D Printing of Scaffolds and Tissues. Engineering. 2015;1:261–268. doi: 10.15302/J-ENG-2015061. [DOI] [Google Scholar]
- 4.Ma H., Feng C., Chang J., Wu C. 3D-printed bioceramic scaffolds: From bone tissue engineering to tumor therapy. Acta Biomater. 2018;79:37–59. doi: 10.1016/j.actbio.2018.08.026. [DOI] [PubMed] [Google Scholar]
- 5.Derby B. Printing and Prototyping of Tissues and Scaffolds. Science. 2012;338:921–926. doi: 10.1126/science.1226340. [DOI] [PubMed] [Google Scholar]
- 6.Turnbull G., Clarke J., Picard F., Riches P., Jia L., Han F., Li B., Shu W. 3D bioactive composite scaffolds for bone tissue engineering. Bioact. Mater. 2018;3:278–314. doi: 10.1016/j.bioactmat.2017.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Best S.M., Porter A.E., Thian E.S., Huang J. Bioceramics: Past, present and for the future. J. Eur. Ceram. Soc. 2008;28:1319–1327. doi: 10.1016/j.jeurceramsoc.2007.12.001. [DOI] [Google Scholar]
- 8.Blokhuis T.J., Arts J.J.C. Bioactive and osteoinductive bone graft substitutes: Definitions, facts and myths. Injury. 2011;42:26–29. doi: 10.1016/j.injury.2011.06.010. [DOI] [PubMed] [Google Scholar]
- 9.Jones J.R., Hench L.L. Regeneration of trabecular bone using porous ceramics. Curr. Opin. Solid State Mater. Sci. 2003;7:301–307. doi: 10.1016/j.cossms.2003.09.012. [DOI] [Google Scholar]
- 10.Schieker M., Seitz H., Drosse I., Seitz S., Mutschler W.J.E.J.O.T. Biomaterials as Scaffold for Bone Tissue Engineering. Eur. J. Trauma. 2006;32:114–124. doi: 10.1007/s00068-006-6047-8. [DOI] [Google Scholar]
- 11.Bose S., Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review. Acta Biomater. 2012;8:1401–1421. doi: 10.1016/j.actbio.2011.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wu S., Liu X., Yeung K.W.K., Liu C., Yang X. Biomimetic porous scaffolds for bone tissue engineering. Mater. Sci. Eng. R Rep. 2014;80:1–36. doi: 10.1016/j.mser.2014.04.001. [DOI] [Google Scholar]
- 13.Brie J., Chartier T., Chaput C., Delage C., Pradeau B., Caire F., Boncoeur M.-P., Moreau J.-J. A new custom made bioceramic implant for the repair of large and complex craniofacial bone defects. J. Cranio Maxillofac. Surg. 2013;41:403–407. doi: 10.1016/j.jcms.2012.11.005. [DOI] [PubMed] [Google Scholar]
- 14.Tang D., Tare R.S., Yang L.-Y., Williams D.F., Ou K.-L., Oreffo R.O.C. Biofabrication of bone tissue: Approaches, challenges and translation for bone regeneration. Biomaterials. 2016;83:363–382. doi: 10.1016/j.biomaterials.2016.01.024. [DOI] [PubMed] [Google Scholar]
- 15.Brunello G., Sivolella S., Meneghello R., Ferroni L., Gardin C., Piattelli A., Zavan B., Bressan E. Powder-based 3D printing for bone tissue engineering. Biotechnol. Adv. 2016;34:740–753. doi: 10.1016/j.biotechadv.2016.03.009. [DOI] [PubMed] [Google Scholar]
- 16.Murphy S.V., Atala A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 2014;32:773. doi: 10.1038/nbt.2958. [DOI] [PubMed] [Google Scholar]
- 17.ASTM F2792-12a. ASTM International; West Conshohocken, PA, USA: 2012. Standard Terminology for Additive Manufacturing Technologies, (Withdrawn 2015) [Google Scholar]
- 18.Gibson I., Rosen D., Stucker B. Additive Manufacturing Technologies: 3D Printing, Rapid Prototyping, and Direct Digital Manufacturing. Springer; New York, NY, USA: 2015. [Google Scholar]
- 19.Miyanaji H., Orth M., Akbar J.M., Yang L.J.F.O.M.E. Process development for green part printing using binder jetting additive manufacturing. Front. Mech. Eng. 2018;13:504–512. doi: 10.1007/s11465-018-0508-8. [DOI] [Google Scholar]
- 20.Snelling D.A., Williams C.B., Suchicital C.T., Druschitz A.P. Binder jetting advanced ceramics for metal-ceramic composite structures. Int. J. Adv. Manuf. Technol. 2017;92:531–545. doi: 10.1007/s00170-017-0139-y. [DOI] [Google Scholar]
- 21.Cima L.G., Cima M.J. Massachusetts Institute of Technology, Assignee. Preparation of Medical Devices by Solid Free-Form Fabrication. Application No. 08138345. U.S. Patent. 1996 Feb 13;
- 22.Sachs E.M., Haggerty J.S., Cima M.J., Williams P.A. Three-Dimensional Printing Techniques. Application No. 5387380A. U.S. Patent. 1995 Feb 7;
- 23.Lu K., Hiser M., Wu W. Effect of particle size on three-dimensional printed mesh structures. Powder Technol. 2009;192:178–183. doi: 10.1016/j.powtec.2008.12.011. [DOI] [Google Scholar]
- 24.Lee J.-Y., An J., Chua C.K. Fundamentals and applications of 3D printing for novel materials. Appl. Mater. Today. 2017;7:120–133. doi: 10.1016/j.apmt.2017.02.004. [DOI] [Google Scholar]
- 25.Balla V.K., Bose S., Bandyopadhyay A. Processing of Bulk Alumina Ceramics Using Laser Engineered Net Shaping. Int. J. Appl. Ceram. Technol. 2008;5:234–242. doi: 10.1111/j.1744-7402.2008.02202.x. [DOI] [Google Scholar]
- 26.Zhai Y., Lados D.A., Brown E.J., Vigilante G.N. Fatigue crack growth behavior and microstructural mechanisms in Ti-6Al-4V manufactured by laser engineered net shaping. Int. J. Fatigue. 2016;93:51–63. doi: 10.1016/j.ijfatigue.2016.08.009. [DOI] [Google Scholar]
- 27.Schiele N., Chrisey D., Corr D. Gelatin-Based Laser Direct-Write Technique for the Precise Spatial Patterning of Cells. Tissue Eng. Part C Methods. 2011;17:289–298. doi: 10.1089/ten.tec.2010.0442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ozbolat I.T., Yu Y. Bioprinting Toward Organ Fabrication: Challenges and Future Trends. IEEE Trans. Biomed. Eng. 2013;60:691–699. doi: 10.1109/TBME.2013.2243912. [DOI] [PubMed] [Google Scholar]
- 29.Ghazanfari A., Li W., Leu M., Hilmas G. A Novel Extrusion-Based Additive Manufacturing Process for Ceramic Parts; Proceedings of the 27th Annual International Solid Freeform Fabrication Symposium; Austin, TX, USA. 8–10 August 2016; pp. 1509–1529. [Google Scholar]
- 30.Deckers J., Vleugels J., Kruth J.P. Additive Manufacturing of Ceramics: A Review. J. Ceram. Sci. Technol. 2014;5:245–260. [Google Scholar]
- 31.Bose S., Suguira S., Bandyopadhyay A. Processing of controlled porosity ceramic structures via fused deposition. Scr. Mater. 1999;41:1009–1014. doi: 10.1016/S1359-6462(99)00250-X. [DOI] [Google Scholar]
- 32.Ozbolat I.T., Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials. 2016;76:321–343. doi: 10.1016/j.biomaterials.2015.10.076. [DOI] [PubMed] [Google Scholar]
- 33.Ji S., Guvendiren M. Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs. Front. Bioeng. Biotechnol. 2017;5:23. doi: 10.3389/fbioe.2017.00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Derby B. Additive Manufacture of Ceramics Components by Inkjet Printing. Engineering. 2015;1:113–123. doi: 10.15302/J-ENG-2015014. [DOI] [Google Scholar]
- 35.Sing S.L., Yeong W.Y., Wiria F.E., Tay B.Y., Zhao Z., Zhao L., Tian Z., Yang S. Direct selective laser sintering and melting of ceramics: A review. Rapid Prototyp. J. 2017;23:611–623. doi: 10.1108/RPJ-11-2015-0178. [DOI] [Google Scholar]
- 36.Qian B., Shen Z. Laser sintering of ceramics. J. Asian Ceram. Soc. 2013;1:315–321. doi: 10.1016/j.jascer.2013.08.004. [DOI] [Google Scholar]
- 37.Kruth J.P., Mercelis P., Van Vaerenbergh J., Froyen L., Rombouts M. Binding mechanisms in selective laser sintering and selective laser melting. Rapid Prototyp. J. 2005;11:26–36. doi: 10.1108/13552540510573365. [DOI] [Google Scholar]
- 38.Bertrand P., Bayle F., Combe C., Goeuriot P., Smurov I. Ceramic components manufacturing by selective laser sintering. Appl. Surf. Sci. 2007;254:989–992. doi: 10.1016/j.apsusc.2007.08.085. [DOI] [Google Scholar]
- 39.Mazzoli A. Selective laser sintering in biomedical engineering. Med. Biol. Eng. Comput. 2013;51:245–256. doi: 10.1007/s11517-012-1001-x. [DOI] [PubMed] [Google Scholar]
- 40.Haeri S. Optimisation of blade type spreaders for powder bed preparation in Additive Manufacturing using DEM simulations. Powder Technol. 2017;321:94–104. doi: 10.1016/j.powtec.2017.08.011. [DOI] [Google Scholar]
- 41.Chartrain N.A., Williams C.B., Whittington A.R. A review on fabricating tissue scaffolds using vat photopolymerization. Acta Biomater. 2018;74:90–111. doi: 10.1016/j.actbio.2018.05.010. [DOI] [PubMed] [Google Scholar]
- 42.Melchels F.P.W., Feijen J., Grijpma D.W. A review on stereolithography and its applications in biomedical engineering. Biomaterials. 2010;31:6121–6130. doi: 10.1016/j.biomaterials.2010.04.050. [DOI] [PubMed] [Google Scholar]
- 43.Stevens A.G., Oliver C.R., Kirchmeyer M., Wu J., Chin L., Polsen E.S., Archer C., Boyle C., Garber J., Hart A.J. Conformal Robotic Stereolithography. 3D Print. Addit. Manuf. 2016;3:226–235. doi: 10.1089/3dp.2016.0042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Li X., Li D., Lu B., Wang C. Fabrication of bioceramic scaffolds with pre-designed internal architecture by gel casting and indirect stereolithography techniques. J. Porous Mater. 2008;15:667–671. doi: 10.1007/s10934-007-9148-9. [DOI] [Google Scholar]
- 45.Wu H., Liu W., He R., Wu Z., Jiang Q., Song X., Chen Y., Cheng L., Wu S. Fabrication of dense zirconia-toughened alumina ceramics through a stereolithography-based additive manufacturing. Ceram. Int. 2017;43:968–972. doi: 10.1016/j.ceramint.2016.10.027. [DOI] [Google Scholar]
- 46.Islam M.N., Gomer H., Sacks S. Comparison of dimensional accuracies of stereolithography and powder binder printing. Int. J. Adv. Manuf. Technol. 2017;88:3077–3087. doi: 10.1007/s00170-016-8988-3. [DOI] [Google Scholar]
- 47.He L., Song X.J.J. Supportability of a High-Yield-Stress Slurry in a New Stereolithography-Based Ceramic Fabrication Process. JOM. 2018;70:407–412. doi: 10.1007/s11837-017-2657-3. [DOI] [Google Scholar]
- 48.Hench L.L. Bioceramics and the origin of life. J. Biomed. Mater. Res. 1989;23:685–703. doi: 10.1002/jbm.820230703. [DOI] [PubMed] [Google Scholar]
- 49.Habraken W., Habibovic P., Epple M., Bohner M. Calcium phosphates in biomedical applications: Materials for the future? Mater. Today. 2016;19:69–87. doi: 10.1016/j.mattod.2015.10.008. [DOI] [Google Scholar]
- 50.Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials. 1991;12:171–178. doi: 10.1016/0142-9612(91)90196-H. [DOI] [PubMed] [Google Scholar]
- 51.Petit R. The use of hydroxyapatite in orthopaedic surgery: A ten-year review. Eur. J. Orthop. Surg. Traumatol. 1999;9:71–74. doi: 10.1007/BF01695730. [DOI] [Google Scholar]
- 52.Zeng Y., Yan Y., Yan H., Liu C., Li P., Dong P., Zhao Y., Chen J. 3D printing of hydroxyapatite scaffolds with good mechanical and biocompatible properties by digital light processing. J. Mater. Sci. 2018;53:6291–6301. doi: 10.1007/s10853-018-1992-2. [DOI] [Google Scholar]
- 53.Szcześ A., Hołysz L., Chibowski E. Synthesis of hydroxyapatite for biomedical applications. Adv. Colloid Interface Sci. 2017;249:321–330. doi: 10.1016/j.cis.2017.04.007. [DOI] [PubMed] [Google Scholar]
- 54.Zhou H., Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011;7:2769–2781. doi: 10.1016/j.actbio.2011.03.019. [DOI] [PubMed] [Google Scholar]
- 55.Bouler J.M., Pilet P., Gauthier O., Verron E. Biphasic calcium phosphate ceramics for bone reconstruction: A review of biological response. Acta Biomater. 2017;53:1–12. doi: 10.1016/j.actbio.2017.01.076. [DOI] [PubMed] [Google Scholar]
- 56.Busuttil Naudi K., Ayoub A., McMahon J., Di Silvio L., Lappin D., Hunter K.D., Barbenel J. Mandibular reconstruction in the rabbit using beta-tricalcium phosphate (β-TCP) scaffolding and recombinant bone morphogenetic protein 7 (rhBMP-7)—Histological, radiographic and mechanical evaluations. J. Cranio Maxillofac. Surg. 2012;40:461–469. doi: 10.1016/j.jcms.2012.03.005. [DOI] [PubMed] [Google Scholar]
- 57.Ryu H.-S., Youn H.-J., Sun Hong K., Chang B.-S., Lee C.-K., Chung S.-S. An improvement in sintering property of β-tricalcium phosphate by adition of calcium pyrophosphate. Biomaterials. 2002;23:909–914. doi: 10.1016/S0142-9612(01)00201-0. [DOI] [PubMed] [Google Scholar]
- 58.Brazete D., Torres P.M.C., Abrantes J.C.C., Ferreira J.M.F. Influence of the Ca/P ratio and cooling rate on the allotropic α β-tricalcium phosphate phase transformations. Ceram. Int. 2018;44:8249–8256. [Google Scholar]
- 59.Fernandes J.S., Gentile P., Pires R.A., Reis R.L., Hatton P.V. Multifunctional bioactive glass and glass-ceramic biomaterials with antibacterial properties for repair and regeneration of bone tissue. Acta Biomater. 2017;59:2–11. doi: 10.1016/j.actbio.2017.06.046. [DOI] [PubMed] [Google Scholar]
- 60.Baino F., Fiorilli S., Vitale-Brovarone C. Bioactive glass-based materials with hierarchical porosity for medical applications: Review of recent advances. Acta Biomater. 2016;42:18–32. doi: 10.1016/j.actbio.2016.06.033. [DOI] [PubMed] [Google Scholar]
- 61.Rahaman M.N., Day D.E., Sonny Bal B., Fu Q., Jung S.B., Bonewald L.F., Tomsia A.P. Bioactive glass in tissue engineering. Acta Biomater. 2011;7:2355–2373. doi: 10.1016/j.actbio.2011.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Liu H., Yazici H., Ergun C., Webster T.J., Bermek H. An in vitro evaluation of the Ca/P ratio for the cytocompatibility of nano-to-micron particulate calcium phosphates for bone regeneration. Acta Biomater. 2008;4:1472–1479. doi: 10.1016/j.actbio.2008.02.025. [DOI] [PubMed] [Google Scholar]
- 63.Parent M., Baradari H., Champion E., Damia C., Viana-Trecant M. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: A review of the parameters affecting the loading and release of the therapeutic substance. J. Control. Release. 2017;252:1–17. doi: 10.1016/j.jconrel.2017.02.012. [DOI] [PubMed] [Google Scholar]
- 64.Ahmad O., Soodeh A. Application of Bioceramics in Orthopedics and Bone Tissue Engineering. [(accessed on 11 October 2019)]; Available online: https://www.researchgate.net/publication/321939283_Application_of_Bioceramics_in_Orthopedics_and_Bone_Tissue_Engineering.
- 65.Hench L.L. Bioceramics: From Concept to Clinic. J. Am. Ceram. Soc. 1991;74:1487–1510. doi: 10.1111/j.1151-2916.1991.tb07132.x. [DOI] [Google Scholar]
- 66.Chevalier J., Gremillard L. Ceramics for medical applications: A picture for the next 20 years. J. Eur. Ceram. Soc. 2009;29:1245–1255. doi: 10.1016/j.jeurceramsoc.2008.08.025. [DOI] [Google Scholar]
- 67.Dorozhkin S.V. Calcium orthophosphate bioceramics. Ceram. Int. 2015;41:13913–13966. doi: 10.1016/j.ceramint.2015.08.004. [DOI] [Google Scholar]
- 68.Oonishi H., Oonishi H., Ohashi H., Kawahara I., Hanaoka Y., Iwata R., Hench L.L. Clinical Applications of Hydroxyapatite in Orthopedics. In: Ben-Nissan B., editor. Advances in Calcium Phosphate Biomaterials. Springer Berlin Heidelberg; Berlin/Heidelberg, Germany: 2014. pp. 19–49. [DOI] [Google Scholar]
- 69.Asri R.I.M., Harun W.S.W., Hassan M.A., Ghani S.A.C., Buyong Z. A review of hydroxyapatite-based coating techniques: Sol-gel and electrochemical depositions on biocompatible metals. J. Mech. Behav. Biomed. Mater. 2016;57:95–108. doi: 10.1016/j.jmbbm.2015.11.031. [DOI] [PubMed] [Google Scholar]
- 70.Cox S.C., Thornby J.A., Gibbons G.J., Williams M.A., Mallick K.K. 3D printing of porous hydroxyapatite scaffolds intended for use in bone tissue engineering applications. Mater. Sci. Eng. C. 2015;47:237–247. doi: 10.1016/j.msec.2014.11.024. [DOI] [PubMed] [Google Scholar]
- 71.Ayoub G., Veljovic D., Zebic M.L., Miletic V., Palcevskis E., Petrovic R., Janackovic D. Composite nanostructured hydroxyapatite/yttrium stabilized zirconia dental inserts—The processing and application as dentin substitutes. Ceram. Int. 2018;44:18200–18208. doi: 10.1016/j.ceramint.2018.07.028. [DOI] [Google Scholar]
- 72.Hung K.-Y., Lo S.-C., Shih C.-S., Yang Y.-C., Feng H.-P., Lin Y.-C. Titanium surface modified by hydroxyapatite coating for dental implants. Surf. Coat. Technol. 2013;231:337–345. doi: 10.1016/j.surfcoat.2012.03.037. [DOI] [Google Scholar]
- 73.Ciobanu G., Harja M. Cerium-doped hydroxyapatite/collagen coatings on titanium for bone implants. Ceram. Int. 2019;45:2852–2857. doi: 10.1016/j.ceramint.2018.07.290. [DOI] [Google Scholar]
- 74.Shi P., Liu M., Fan F., Yu C., Lu W., Du M. Characterization of natural hydroxyapatite originated from fish bone and its biocompatibility with osteoblasts. Mater. Sci. Eng. C. 2018;90:706–712. doi: 10.1016/j.msec.2018.04.026. [DOI] [PubMed] [Google Scholar]
- 75.Carfì Pavia F., Conoscenti G., Greco S., La Carrubba V., Ghersi G., Brucato V. Preparation, characterization and in vitro test of composites poly-lactic acid/hydroxyapatite scaffolds for bone tissue engineering. Int. J. Biol. Macromol. 2018;119:945–953. doi: 10.1016/j.ijbiomac.2018.08.007. [DOI] [PubMed] [Google Scholar]
- 76.He X., Fan X., Feng W., Chen Y., Guo T., Wang F., Liu J., Tang K. Incorporation of microfibrillated cellulose into collagen-hydroxyapatite scaffold for bone tissue engineering. Int. J. Biol. Macromol. 2018;115:385–392. doi: 10.1016/j.ijbiomac.2018.04.085. [DOI] [PubMed] [Google Scholar]
- 77.Sposito Corcione C., Gervaso F., Scalera F., Padmanabhan S.K., Madaghiele M., Montagna F., Sannino A., Licciulli A., Maffezzoli A. Highly loaded hydroxyapatite microsphere/ PLA porous scaffolds obtained by fused deposition modelling. Ceram. Int. 2019;45:2803–2810. doi: 10.1016/j.ceramint.2018.07.297. [DOI] [Google Scholar]
- 78.Barry J.J.A., Evseev A.V., Markov M.A., Upton C.E., Scotchford C.A., Popov V.K., Howdle S.M. In vitro study of hydroxyapatite-based photocurable polymer composites prepared by laser stereolithography and supercritical fluid extraction. Acta Biomater. 2008;4:1603–1610. doi: 10.1016/j.actbio.2008.05.024. [DOI] [PubMed] [Google Scholar]
- 79.Li Q., Lei X., Wang X., Cai Z., Lyu P., Zhang G. Hydroxyapatite/Collagen Three-Dimensional Printed Scaffolds and Their Osteogenic Effects on Human Bone Marrow-Derived Mesenchymal Stem Cells. Tissue Eng. Part A. 2019;25:1261–1271. doi: 10.1089/ten.tea.2018.0201. [DOI] [PubMed] [Google Scholar]
- 80.Woesz A., Rumpler M., Stampfl J., Varga F., Fratzl-Zelman N., Roschger P., Klaushofer K., Fratzl P. Towards bone replacement materials from calcium phosphates via rapid prototyping and ceramic gelcasting. Mater. Sci. Eng. C. 2005;25:181–186. doi: 10.1016/j.msec.2005.01.014. [DOI] [Google Scholar]
- 81.Saiz E., Gremillard L., Menendez G., Miranda P., Gryn K., Tomsia A.P. Preparation of porous hydroxyapatite scaffolds. Mater. Sci. Eng. C. 2007;27:546–550. doi: 10.1016/j.msec.2006.05.038. [DOI] [Google Scholar]
- 82.Virginie K., Fabien G., Isabelle A., Bertrand G., Sylvain M., Joëlle A., Jean-Christophe F., Sylvain C. In vivo bioprinting for computer- and robotic-assisted medical intervention: preliminary study in mice. Biofabrication. 2010;2:014101. doi: 10.1088/1758-5082/2/1/014101. [DOI] [PubMed] [Google Scholar]
- 83.Tian Y., Lu T., He F., Xu Y., Shi H., Shi X., Zuo F., Wu S., Ye J. β-tricalcium phosphate composite ceramics with high compressive strength, enhanced osteogenesis and inhibited osteoclastic activities. Colloids Surf. B Biointerfaces. 2018;167:318–327. doi: 10.1016/j.colsurfb.2018.04.028. [DOI] [PubMed] [Google Scholar]
- 84.Hirakawa Y., Manaka T., Orita K., Ito Y., Ichikawa K., Nakamura H. The accelerated effect of recombinant human bone morphogenetic protein 2 delivered by β-tricalcium phosphate on tendon-to-bone repair process in rabbit models. J. Shoulder Elb. Surg. 2018;27:894–902. doi: 10.1016/j.jse.2017.11.025. [DOI] [PubMed] [Google Scholar]
- 85.Cheng L., Duan X., Xiang Z., Shi Y., Lu X., Ye F., Bu H. Ectopic bone formation cannot occur by hydroxyapatite/β-tricalcium phosphate bioceramics in green fluorescent protein chimeric mice. Appl. Surf. Sci. 2012;262:200–206. doi: 10.1016/j.apsusc.2012.04.168. [DOI] [Google Scholar]
- 86.Stähli C., Bohner M., Bashoor-Zadeh M., Doebelin N., Baroud G. Aqueous impregnation of porous β-tricalcium phosphate scaffolds. Acta Biomater. 2010;6:2760–2772. doi: 10.1016/j.actbio.2010.01.018. [DOI] [PubMed] [Google Scholar]
- 87.Horch H.H., Sader R., Pautke C., Neff A., Deppe H., Kolk A. Synthetic, pure-phase beta-tricalcium phosphate ceramic granules for bone regeneration in the reconstructive surgery of the jaws. Int. J. Oral Maxillofac. Surg. 2006;35:708–713. doi: 10.1016/j.ijom.2006.03.017. [DOI] [PubMed] [Google Scholar]
- 88.Zerbo I.R., Bronckers A.L.J.J., De Lange G.L., Burger E.H., Van Beek G.J. Histology of human alveolar bone regeneration with a porous tricalcium phosphate. Clin. Oral Implant. Res. 2001;12:379–384. doi: 10.1034/j.1600-0501.2001.012004379.x. [DOI] [PubMed] [Google Scholar]
- 89.Li B., Liu Z., Yang J., Yi Z., Xiao W., Liu X., Yang X., Xu W., Liao X. Preparation of bioactive β-tricalcium phosphate microspheres as bone graft substitute materials. Mater. Sci. Eng. C. 2017;70:1200–1205. doi: 10.1016/j.msec.2016.03.040. [DOI] [PubMed] [Google Scholar]
- 90.Cao Y., Xiao L., Cao Y., Nanda A., Xu C., Ye Q. 3D printed β-TCP scaffold with sphingosine 1-phosphate coating promotes osteogenesis and inhibits inflammation. Biochem. Biophys. Res. Commun. 2019;512:889–895. doi: 10.1016/j.bbrc.2019.03.132. [DOI] [PubMed] [Google Scholar]
- 91.Bian W., Li D., Lian Q., Li X., Zhang W., Wang K., Jin Z. Fabrication of a bio-inspired beta-Tricalcium phosphate/collagen scaffold based on ceramic stereolithography and gel casting for osteochondral tissue engineering. Rapid Prototyp. J. 2012;18:68–80. doi: 10.1108/13552541211193511. [DOI] [Google Scholar]
- 92.Bose S., Banerjee D., Robertson S., Vahabzadeh S. Enhanced In Vivo Bone and Blood Vessel Formation by Iron Oxide and Silica Doped 3D Printed Tricalcium Phosphate Scaffolds. Ann. Biomed. Eng. 2018;46:1241–1253. doi: 10.1007/s10439-018-2040-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Tarafder S., Balla V.K., Davies N.M., Bandyopadhyay A., Bose S. Microwave-sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering. J. Tissue Eng. Regen. Med. 2013;7:631–641. doi: 10.1002/term.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: An update. Injury. 2005;36:20–27. doi: 10.1016/j.injury.2005.07.029. [DOI] [PubMed] [Google Scholar]
- 95.Välimäki V.-V., Aro H. Molecular basis for action of bioactive glasses as bone graft substitute. Scand. J. Surg. 2006;95:95–102. doi: 10.1177/145749690609500204. [DOI] [PubMed] [Google Scholar]
- 96.Eqtesadi S., Motealleh A., Miranda P., Pajares A., Lemos A., Ferreira J.M.F. Robocasting of 45S5 bioactive glass scaffolds for bone tissue engineering. J. Eur. Ceram. Soc. 2014;34:107–118. doi: 10.1016/j.jeurceramsoc.2013.08.003. [DOI] [Google Scholar]
- 97.Xynos I.D., Edgar A.J., Buttery L.D.K., Hench L.L., Polak J.M. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J. Biomed. Mater. Res. 2001;55:151–157. doi: 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
- 98.Wu C., Luo Y., Cuniberti G., Xiao Y., Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011;7:2644–2650. doi: 10.1016/j.actbio.2011.03.009. [DOI] [PubMed] [Google Scholar]
- 99.Pei P., Tian Z., Zhu Y. 3D printed mesoporous bioactive glass/metal-organic framework scaffolds with antitubercular drug delivery. Microporous Mesoporous Mater. 2018;272:24–30. doi: 10.1016/j.micromeso.2018.06.012. [DOI] [Google Scholar]
- 100.Baino F. Bioactive glasses—When glass science and technology meet regenerative medicine. Ceram. Int. 2018;44:14953–14966. doi: 10.1016/j.ceramint.2018.05.180. [DOI] [Google Scholar]
- 101.Hsu F.-Y., Hsu H.-W., Chang Y.-H., Yu J.-L., Rau L.-R., Tsai S.-W. Macroporous microbeads containing apatite-modified mesoporous bioactive glass nanofibres for bone tissue engineering applications. Mater. Sci. Eng. C. 2018;89:346–354. doi: 10.1016/j.msec.2018.04.027. [DOI] [PubMed] [Google Scholar]
- 102.Nommeots-Nomm A., Lee P.D., Jones J.R. Direct ink writing of highly bioactive glasses. J. Eur. Ceram. Soc. 2018;38:837–844. doi: 10.1016/j.jeurceramsoc.2017.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Padilla S., Sánchez-Salcedo S., Vallet-Regí M. Bioactive glass as precursor of designed-architecture scaffolds for tissue engineering. J. Biomed. Mater. Res. Part A. 2007;81:224–232. doi: 10.1002/jbm.a.30934. [DOI] [PubMed] [Google Scholar]
- 104.Westhauser F., Weis C., Prokscha M., Bittrich L.A., Li W., Xiao K., Kneser U., Kauczor H.-U., Schmidmaier G., Boccaccini A.R., et al. Three-dimensional polymer coated 45S5-type bioactive glass scaffolds seeded with human mesenchymal stem cells show bone formation in vivo. J. Mater. Sci. Mater. Med. 2016;27:119. doi: 10.1007/s10856-016-5732-3. [DOI] [PubMed] [Google Scholar]
- 105.Liu Z., Liang H., Shi T., Xie D., Chen R., Han X., Shen L., Wang C., Tian Z. Additive manufacturing of hydroxyapatite bone scaffolds via digital light processing and in vitro compatibility. Ceram. Int. 2019;45:11079–11086. doi: 10.1016/j.ceramint.2019.02.195. [DOI] [Google Scholar]
- 106.Wang Y., Wang K., Li X., Wei Q., Chai W., Wang S., Che Y., Lu T., Zhang B. 3D fabrication and characterization of phosphoric acid scaffold with a HA/beta-TCP weight ratio of 60:40 for bone tissue engineering applications. PLoS ONE. 2017;12:e0174870. doi: 10.1371/journal.pone.0174870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Tarafder S., Bose S. Polycaprolactone-Coated 3D Printed Tricalcium Phosphate Scaffolds for Bone Tissue Engineering: In Vitro Alendronate Release Behavior and Local Delivery Effect on In Vivo Osteogenesis. ACS Appl. Mater. Interfaces. 2014;6:9955–9965. doi: 10.1021/am501048n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Luo G., Ma Y., Cui X., Jiang L., Wu M., Hu Y., Luo Y., Pan H., Ruan C. 13-93 bioactive glass/alginate composite scaffolds 3D printed under mild conditions for bone regeneration. RSC Adv. 2017;7:11880–11889. doi: 10.1039/C6RA27669E. [DOI] [Google Scholar]
- 109.Dimitriou R., Jones E., McGonagle D., Giannoudis P. Bone regeneration: current concepts and future directions. BMC Med. 2011;9:66. doi: 10.1186/1741-7015-9-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Pilia M., Guda T., Appleford M. Development of Composite Scaffolds for Load-Bearing Segmental Bone Defects. BioMed Res. Int. 2013;2013:458253. doi: 10.1155/2013/458253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Reichert J.C., Wullschleger M.E., Cipitria A., Lienau J., Cheng T.K., Schütz M.A., Duda G.N., Nöth U., Eulert J., Hutmacher D. Custom-made composite scaffolds for segmental defect repair in long bones. Int. Orthop. 2011;35:1229–1236. doi: 10.1007/s00264-010-1146-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Wagoner Johnson A.J., Herschler B.A. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater. 2011;7:16–30. doi: 10.1016/j.actbio.2010.07.012. [DOI] [PubMed] [Google Scholar]
- 113.Chengtie W., Jiang C. A review of bioactive silicate ceramics. Biomed. Mater. 2013;8:032001. doi: 10.1088/1748-6041/8/3/032001. [DOI] [PubMed] [Google Scholar]
- 114.Fu Q., Saiz E., Rahaman M.N., Tomsia A.P. Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater. Sci. Eng. C. 2011;31:1245–1256. doi: 10.1016/j.msec.2011.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Rezwan K., Chen Q.Z., Blaker J.J., Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27:3413–3431. doi: 10.1016/j.biomaterials.2006.01.039. [DOI] [PubMed] [Google Scholar]
- 116.Vorndran E., Klarner M., Klammert U., Grover L.M., Patel S., Barralet J.E., Gbureck U. 3D Powder Printing of β-Tricalcium Phosphate Ceramics Using Different Strategies. Adv. Eng. Mater. 2008;10:67–71. doi: 10.1002/adem.200800179. [DOI] [Google Scholar]
- 117.Detsch R., Schaefer S., Deisinger U., Ziegler G., Seitz H., Leukers B. In vitro -Osteoclastic Activity Studies on Surfaces of 3D Printed Calcium Phosphate Scaffolds. J. Biomater. Appl. 2011;26:359–380. doi: 10.1177/0885328210373285. [DOI] [PubMed] [Google Scholar]
- 118.Fielding G., Bose S. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater. 2013;9:9137–9148. doi: 10.1016/j.actbio.2013.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Wang Y., Li X., Wei Q., Yang M., Wei S. Study on the Mechanical Properties of Three-Dimensional Directly Binding Hydroxyapatite Powder. Cell Biochem. Biophys. 2015;72:289–295. doi: 10.1007/s12013-014-0452-0. [DOI] [PubMed] [Google Scholar]
- 120.Miguel C., Marta D., Elke V., Uwe G., Paulo F., Inês P., Barbara G., Henrique A., Eduardo P., Jorge R. Application of a 3D printed customized implant for canine cruciate ligament treatment by tibial tuberosity advancement. Biofabrication. 2014;6:025005. doi: 10.1088/1758-5082/6/2/025005. [DOI] [PubMed] [Google Scholar]
- 121.Butscher A., Bohner M., Doebelin N., Hofmann S., Müller R. New depowdering-friendly designs for three-dimensional printing of calcium phosphate bone substitutes. Acta Biomater. 2013;9:9149–9158. doi: 10.1016/j.actbio.2013.07.019. [DOI] [PubMed] [Google Scholar]
- 122.Chumnanklang R., Panyathanmaporn T., Sitthiseripratip K., Suwanprateeb J. 3D printing of hydroxyapatite: Effect of binder concentration in pre-coated particle on part strength. Mater. Sci. Eng. C. 2007;27:914–921. doi: 10.1016/j.msec.2006.11.004. [DOI] [Google Scholar]
- 123.Suwanprateeb J., Sanngam R., Suvannapruk W., Panyathanmaporn T. Mechanical and in vitro performance of apatite—Wollastonite glass ceramic reinforced hydroxyapatite composite fabricated by 3D-printing. J. Mater. Sci. Mater. Med. 2009;20:1281. doi: 10.1007/s10856-009-3697-1. [DOI] [PubMed] [Google Scholar]
- 124.Hwa L.C., Rajoo S., Noor A.M., Ahmad N., Uday M.B. Recent advances in 3D printing of porous ceramics: A review. Curr. Opin. Solid State Mater. Sci. 2017;21:323–347. doi: 10.1016/j.cossms.2017.08.002. [DOI] [Google Scholar]
- 125.Roohani-Esfahani S.-I., Newman P., Zreiqat H. Design and Fabrication of 3D printed Scaffolds with a Mechanical Strength Comparable to Cortical Bone to Repair Large Bone Defects. Sci. Rep. 2016;6:19468. doi: 10.1038/srep19468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Fierz F.C., Beckmann F., Huser M., Irsen S.H., Leukers B., Witte F., Degistirici Ö., Andronache A., Thie M., Müller B. The morphology of anisotropic 3D-printed hydroxyapatite scaffolds. Biomaterials. 2008;29:3799–3806. doi: 10.1016/j.biomaterials.2008.06.012. [DOI] [PubMed] [Google Scholar]
- 127.Dellinger J.G., Eurell J.A.C., Jamison R.D. Bone response to 3D periodic hydroxyapatite scaffolds with and without tailored microporosity to deliver bone morphogenetic protein 2. J. Biomed. Mater. Res. 2006;76:366–376. doi: 10.1002/jbm.a.30523. [DOI] [PubMed] [Google Scholar]
- 128.Hollinger J.O., Brekke J., Gruskin E., Lee D. Role of Bone Substitutes. Clin. Orthop. Relat. Res. 1996;324:55–65. doi: 10.1097/00003086-199603000-00008. [DOI] [PubMed] [Google Scholar]
- 129.Kaully T., Kaufman-Francis K., Lesman A., Levenberg S. Vascularization—The Conduit to Viable Engineered Tissues. Tissue Eng. Part B Rev. 2009;15:159–169. doi: 10.1089/ten.teb.2008.0193. [DOI] [PubMed] [Google Scholar]
- 130.Shahabipour F., Ashammakhi N., Oskuee R.K., Bonakdar S., Hoffman T., Shokrgozar M.A., Khademhosseini A. Key components of engineering vascularized 3-dimensional bioprinted bone constructs. Transl. Res. 2019 doi: 10.1016/j.trsl.2019.08.010. [DOI] [PubMed] [Google Scholar]
- 131.Jammalamadaka U., Tappa K. Recent Advances in Biomaterials for 3D Printing and Tissue Engineering. J. Funct. Biomater. 2018;9:22. doi: 10.3390/jfb9010022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Tappa K., Jammalamadaka U. Novel Biomaterials Used in Medical 3D Printing Techniques. J. Funct. Biomater. 2018;9:17. doi: 10.3390/jfb9010017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Kolesky D.B., Homan K.A., Skylar-Scott M.A., Lewis J.A. Three-dimensional bioprinting of thick vascularized tissues. Proc. Natl. Acad. Sci. USA. 2016;113:3179–3184. doi: 10.1073/pnas.1521342113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Bertassoni L., Cecconi M., Manoharan V., Nikkhah M., Hjortnaes J., Cristino A., Barabaschi G., Demarchi D., Dokmeci M., Yang Y., et al. Hydrogel Bioprinted Microchannel Networks for Vascularization of Tissue Engineering Constructs. Lab Chip. 2014;14:2202–2211. doi: 10.1039/C4LC00030G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Zhang A.P., Qu X., Soman P., Hribar K.C., Lee J.W., Chen S., He S. Rapid Fabrication of Complex 3D Extracellular Microenvironments by Dynamic Optical Projection Stereolithography. Adv. Mater. 2012;24:4266–4270. doi: 10.1002/adma.201202024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Tumbleston J., Shirvanyants D., Ermoshkin N., Janusziewicz R., Johnson A., Kelly D., Chen K., Pinschmidt R., Rolland J., Ermoshkin A., et al. Additive manufacturing. Continuous liquid interface production of 3D objects. Science. 2015;347:1349–1352. doi: 10.1126/science.aaa2397. [DOI] [PubMed] [Google Scholar]
- 137.Zhu W., Qu X., Zhu J., Ma X., Patel S., Liu J., Wang P., Lai C.S.E., Gou M., Xu Y., et al. Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture. Biomaterials. 2017;124:106–115. doi: 10.1016/j.biomaterials.2017.01.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Araldi E., Schipani E. Hypoxia, HIFs and bone development. Bone. 2010;47:190–196. doi: 10.1016/j.bone.2010.04.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Kuss M.A., Harms R., Wu S., Wang Y., Untrauer J.B., Carlson M.A., Duan B. Short-term hypoxic preconditioning promotes prevascularization in 3D bioprinted bone constructs with stromal vascular fraction derived cells. RSC Adv. 2017;7:29312–29320. doi: 10.1039/C7RA04372D. [DOI] [PMC free article] [PubMed] [Google Scholar]